StockData
Omeros Corp logo

Omeros Corp (OMER) stock

OMERNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 1/30
$14.55+0.63 (+4.53%)

Close on Nov 18, 2026Market cap $1.05BP/E –Yield –

Omeros operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Omeros's operating income for the twelve months ending Jun 30, 2026 was -$72.82M. For fiscal 2025 it was -$122.80M. The highest annual figure on record is -$20.76M in fiscal 2009.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$122.80M–
FY2024Dec 31, 2024-$166.95M–
FY2023Dec 31, 2023-$164.53M–
FY2022Dec 31, 2022-$163.39M–
FY2021Dec 31, 2021-$173.62M–
FY2020Dec 31, 2020-$156.92M–
FY2019Dec 31, 2019-$146.04M–
FY2018Dec 31, 2018-$112.22M–
FY2017Dec 31, 2017-$43.90M–
FY2016Dec 31, 2016-$54.28M–
FY2015Dec 31, 2015-$71.24M–
FY2014Dec 31, 2014-$70.01M–
FY2013Dec 31, 2013-$50.52M–
FY2012Dec 31, 2012-$36.89M–
FY2011Dec 31, 2011-$27.41M–
FY2010Dec 31, 2010-$30.11M–
FY2009Dec 31, 2009-$20.76M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$74.00K–
Q1 FY2026Mar 31, 2026-$17.42M–
Q4 FY2025Dec 31, 2025-$29.08M–
Q3 FY2025Sep 30, 2025-$26.39M–
Q2 FY2025Jun 30, 2025-$32.35M–
Q1 FY2025Mar 31, 2025-$34.97M–
Q4 FY2024Dec 31, 2024-$33.36M–
Q3 FY2024Sep 30, 2024-$35.41M–
Q2 FY2024Jun 30, 2024-$59.16M–
Q1 FY2024Mar 31, 2024-$39.03M–
Q4 FY2023Dec 31, 2023-$39.77M–
Q3 FY2023Sep 30, 2023-$48.15M–
Q2 FY2023Jun 30, 2023-$40.90M–
Q1 FY2023Mar 31, 2023-$35.71M–
Q4 FY2022Dec 31, 2022-$40.14M–
Q3 FY2022Sep 30, 2022-$50.77M–
Q2 FY2022Jun 30, 2022-$37.44M–
Q1 FY2022Mar 31, 2022-$35.05M–
Q4 FY2021Dec 31, 2021-$42.89M–
Q1 FY2021Mar 31, 2021-$45.29M–
Q4 FY2020Dec 31, 2020-$33.82M–
Q3 FY2020Sep 30, 2020-$25.43M–
Q2 FY2020Jun 30, 2020-$27.68M–
Q1 FY2020Mar 31, 2020-$23.68M–
Q4 FY2019Dec 31, 2019-$23.70M–
Q3 FY2019Sep 30, 2019-$11.10M–
Q2 FY2019Jun 30, 2019-$9.34M–
Q1 FY2019Mar 31, 2019-$19.24M–
Q4 FY2018Dec 31, 2018-$18.47M–
Q3 FY2018Sep 30, 2018-$35.44M–
Q2 FY2018Jun 30, 2018-$30.62M–
Q1 FY2018Mar 31, 2018-$27.69M–
Q4 FY2017Dec 31, 2017-$14.12M–
Q3 FY2017Sep 30, 2017-$5.11M–
Q2 FY2017Jun 30, 2017-$11.94M–
Q1 FY2017Mar 31, 2017-$12.73M–
Q4 FY2016Dec 31, 2016-$11.86M–
Q3 FY2016Sep 30, 2016-$12.04M–
Q2 FY2016Jun 30, 2016-$10.93M–

More Omeros figures

See a number that looks wrong?